Skip to main content

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

LXRX holding history

Lexicon Pharmaceuticals, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LXRX overviewAll 13F holders of LXRXFull Q2 2026 holdings

Shares (Q2 2026)
32,588
Value
$78.2K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of LXRX by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202632,588$78.2K<0.1%+32,588NewHolders
Q4 20250$00.0%−12,946−100.0%Sold outHolders
Q3 202512,946$17.5K<0.1%−615−4.5%ReducedHolders
Q2 202513,561$12.8K<0.1%−27,601−67.1%ReducedHolders
Q1 202541,162$19.0K<0.1%−8,298−16.8%ReducedHolders
Q4 202449,460$36.5K<0.1%+6,404+14.9%AddedHolders
Q3 202443,056$67.6K<0.1%+8,331+24.0%AddedHolders
Q2 202434,725$58.3K<0.1%+979+2.9%AddedHolders
Q1 202433,746$81.0K<0.1%+2,764+8.9%AddedHolders
Q4 202330,982$47.4K<0.1%+2,933+10.5%AddedHolders
Q3 202328,049$30.6K<0.1%+3,734+15.4%AddedHolders
Q2 202324,315$55.7K<0.1%+1,429+6.2%AddedHolders
Q1 202322,886$55.6K<0.1%−3,438−13.1%ReducedHolders
Q4 202226,324$50.3K<0.1%+1,699+6.9%AddedHolders
Q3 202224,625$59.0K<0.1%+4,793+24.2%AddedHolders
Q2 202219,832$37.0K<0.1%−8,703−30.5%ReducedHolders
Q1 202228,535$60.0K<0.1%−7,722−21.3%ReducedHolders
Q4 202136,257$143.0K<0.1%+36,257NewHolders
Q3 20210$00.0%−17,612−100.0%Sold outHolders
Q2 202117,612$81.0K<0.1%+4,323+32.5%AddedHolders
Q1 202113,289$78.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.